C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2004
12/23/2004	US20040259126 MN gene and protein
12/23/2004	US20040259122 Autocatalysis/yeast two-hybrid assay
12/23/2004	US20040259114 Coactivators in the diagnosis and treatment of breast cancer
12/23/2004	US20040259110 Gene PRV-1 and its use
12/23/2004	US20040259107 nucleotide sequence is associated with hereditary ferritinopathy; use in diagnosis; drug screening using animal models; antibodies
12/23/2004	US20040259102 Detection of chemical ligation using fluorescence quenching leaving groups
12/23/2004	US20040259092 Nogo receptor homologues and their use
12/23/2004	US20040259086 Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of human prostate cancer
12/23/2004	US20040259075 For blocking entry into cells and inhibiting replication; chemokine receptors
12/23/2004	US20040258715 Porcine circoviruses, vaccines and diagnostic reagents
12/23/2004	US20040258713 Attenuated mutant newcastle disease virus strains for in ovo vaccination, method for preparing and their use
12/23/2004	US20040258710 Novel polypeptides and nucleic acids encoding Bolekine
12/23/2004	US20040258709 Hepatitis B virus polypeptides
12/23/2004	US20040258708 Cytotoxic T-cell epitopes of papillomavirus L1 protein and their use in diagnostics and therapy
12/23/2004	US20040258707 Nucleotide sequences encoding the structural proteins (causative agent) which consists of a basic capsid protein, three envelope proteins designated as E1, E2 and E3, and a 6K protein; stable DNA vaccines and vector vaccines of live attenuated modified bacteria or virus; kits for medical diagnosis
12/23/2004	US20040258706 Cyanovirin variant-polymer conjugates
12/23/2004	US20040258704 Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation
12/23/2004	US20040258697 Methods of using multivalent MHC class II-peptide chimeras
12/23/2004	US20040258695 Transferrin binding peptides and uses thereof
12/23/2004	US20040258694 Hepatitis C receptor protein CD81
12/23/2004	US20040258691 Treating psoriasis in a patient by administering a therapeutically effective amount of an antibody immunospecific for vetronectin receptor av beta 3; antiinflammatory agents; antibody does not immunoreact with integrins other than av beta 3; cell adhesion
12/23/2004	US20040258688 Long lasting immunity using single dose at low concentration; exposing dendritic cells to antigen-antibody-DEC-205 receptor conjugate or to recombinant anti-DEC-205 antibody and promoting maturation
12/23/2004	US20040258686 Mammalian receptor proteins; related reagents and methods
12/23/2004	US20040258681 Nucleic acid and amino acid sequences; purified antibodies, expression vectors, host cells
12/23/2004	US20040258679 Nucleic and amino acid sequences; autoimmune/inflammatory disorders, cancer; expression vectors, host cells, antibodies, agonists, antagonists. transgenic organisms
12/23/2004	US20040258678 Isolated nucleic acid having high identity to sequence 215; vectors, host cells, antibodies
12/23/2004	US20040258660 Tumor necrosis factor alpha analogues having three dimensional structure of similar to proteins from which they are derived; facilitating correct folding
12/23/2004	US20040258659 Design and/or selection of phage agonists or antagonists towards G protein coupled receptor ligands; enhanced anti-HIV-1 activity compared to RANTES
12/23/2004	US20040258656 Identified via SELEX method; phosphate-containing ligand is conjugated to polyoxyethylene glycol; transforming growth factor (TGF); pharmacokinetics
12/23/2004	US20040258619 Diaminedioxime radiometal complexes
12/23/2004	US20040258616 Compositions and methods for treating cancer using IGSF9 and LIV-1
12/23/2004	DE10325639A1 Determining particular conditions or alterations in the uterine mucosa, useful e.g. for assessing receptivity for implantation, by measuring concentration of specific forms of human chorionogonadotrophin
12/23/2004	DE10325638A1 Determining particular conditions or alterations in the uterine mucosa, useful e.g. for assessing receptivity for implantation, by measuring concentration of specific forms of human chorionogonadotrophin
12/23/2004	DE10325049A1 New peptide derivatives containing cell-adhesion molecule and phosphonate-containing anchor component, useful for treating disorders associated with implants, are inhibitors of integrins
12/23/2004	DE10324799A1 New crystalline ligand-binding domain of the ecdysone receptor, useful for identifying specific ligands, potentially useful as insecticides and for controlling expression of target gene
12/23/2004	DE10235248B4 Fusionsprotein mit verstärkter in vivo-Aktivität von Erythropoietin Fusion protein with enhanced in vivo activity of erythropoietin
12/23/2004	CA2531890A1 Peptides enhancing ceh activity or inhibiting acat activity for treating atherosclerosis
12/23/2004	CA2530972A1 Platelet glycoprotein ib alpha variant fusion polypeptides and methods of use thereof
12/23/2004	CA2529828A1 Factor vii or viia gla domain variants
12/23/2004	CA2529814A1 Chemokine-binding protein thap1, methods and use thereof
12/23/2004	CA2529583A1 Oxidoreductase from pichia capsulata
12/23/2004	CA2529496A1 Anti-cd74 immunoconjugates and methods
12/23/2004	CA2529309A1 Viral polymerase and modulation thereof
12/23/2004	CA2528958A1 Combinatorial nucleobase oligomers comprising universal base analogues and methods for making and using same
12/23/2004	CA2528741A1 Methods for the production of insulin in plants
12/23/2004	CA2528418A1 Method to increase protein production in culture
12/23/2004	CA2528253A1 Methods for detecting cancer and monitoring cancer progression
12/23/2004	CA2528240A1 Compound containing polyprotein ns3/ns4 and hcv polypeptide ns5b, expression vectors comprising corresponding nucleic sequences and the therapeutic application thereof
12/23/2004	CA2528186A1 Molecules for targeting and releasing therapeutic compounds, and the use thereof
12/23/2004	CA2527954A1 Modified fiber proteins for efficient receptor binding
12/23/2004	CA2527863A1 Cell surface protein associated with human chronic lymphocytic leukemia
12/23/2004	CA2527822A1 Room temperature storage of organs
12/23/2004	CA2527735A1 Functionally reconstituted viral membranes containing adjuvant
12/23/2004	CA2526753A1 Sdr proteins from staphylococcus capitis and their use in preventing and treating infections
12/23/2004	CA2526169A1 Fusion proteins
12/23/2004	CA2525778A1 T cell epitopes useful in a severe acute respiratory syndrome (sars) virus vaccine and as diagnostic tools and methods for identifying same
12/23/2004	CA2525584A1 Transgenic animal having an amyloid precursor protein with a modified beta secretase cleavage site
12/23/2004	CA2525517A1 Use of prion conversion modulating agents
12/23/2004	CA2524325A1 Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
12/23/2004	CA2514288A1 Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease
12/22/2004	EP1489189A1 Diagnostics and remedies for malignant brain tumor
12/22/2004	EP1489185A1 Methods and compositions for use in splicesome mediated rna trans-splicing
12/22/2004	EP1489182A1 Gene participating in acetic acid tolerance, acetic acid bacterium bred using the gene, and process for producing vinegar with the use of the acetic acid bacterium
12/22/2004	EP1489180A1 P18abeta rp gene and p18abeta rp protein, novel gene/protein (p60trp) interacting therewith to inhibit cell death and cell death promoter
12/22/2004	EP1489179A1 Antiopoietin-related growth factor
12/22/2004	EP1489178A1 Polypeptides binding to human syntaxin 1a
12/22/2004	EP1489176A1 Fluorescent protein
12/22/2004	EP1489172A1 Nuclear receptor err gamma 3
12/22/2004	EP1489170A1 Transporter selectively transporting sulfate conjugate and its gene
12/22/2004	EP1489168A1 Protein sustaining undifferentiated stem cells as such
12/22/2004	EP1489165A1 Recombinant fowlpox vaccine for protection against marek's disease
12/22/2004	EP1489100A2 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
12/22/2004	EP1489099A2 Antibodies that bind the CD40CR receptor
12/22/2004	EP1489097A1 Inhibitors of human plasmin derived from kunitz domains and nucleic acids encoding the same
12/22/2004	EP1489096A1 Novel hemepeptide
12/22/2004	EP1489095A1 Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer
12/22/2004	EP1489094A1 Nuclear receptor rxr alpha isoforms
12/22/2004	EP1489093A1 Peptides, medicinal compositions containing the peptide and medicinal compositions for treating cancer
12/22/2004	EP1488805A2 CD28 pathway immunoregulation
12/22/2004	EP1488803A1 Neurotoxic component of botulinum toxins for treating neuromuscular disorders
12/22/2004	EP1488799A2 Soluble lymphotosin-Beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
12/22/2004	EP1488233A2 Novel acidic mammalian proteins and polynucleotides encoding the same
12/22/2004	EP1488231A2 Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof
12/22/2004	EP1487991A2 Cancer-linked gene as target for chemotherapy
12/22/2004	EP1487989A2 Molecules for disease detection and treatment
12/22/2004	EP1487988A2 Novel nucleic acids and secreted polypeptides
12/22/2004	EP1487984A1 Dna vaccines encoding cea and a cd40 ligand and methods of use thereof
12/22/2004	EP1487981A2 Growth regulating proteins
12/22/2004	EP1487972A2 Mn/ca ix-specific monoclonal antibodies generated from mn/ca ix-deficient mice and methods of use
12/22/2004	EP1487971A2 MEANS AND METHODS FOR MANIPULATING HYPERSENSITIVITY−LIKE RESPONSES
12/22/2004	EP1487964A2 POLYNUCLEOTIDE ENCODING A NOVEL HUMAN POTASSIUM CHANNEL ALPHA-SUBUNIT, K+alphaM1, AND VARIANTS THEREOF
12/22/2004	EP1487877A2 Compositions and methods for the diagnosis and treatment of tumor
12/22/2004	EP1487876A1 The use of an epitope of vascular endothelial growth factor receptor kdr/flk-1
12/22/2004	EP1487875A2 Antibody that binds to a dimer of a prion protein for the treatment of tse infection
12/22/2004	EP1487874A1 Falp proteins
12/22/2004	EP1487873A1 P-rex1, a ptdins(3,4,5)p3- g-beta-gamma-regulated guanine-nucleotide exchange factor for rac
12/22/2004	EP1487872A1 Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions
12/22/2004	EP1487870A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
12/22/2004	EP1487869A1 Novel allergen
12/22/2004	EP1487868A1 Chimeric delta endotoxin protein of cry1ea and cry1ca

1 ... 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 ... 2916